We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

65 hedge funds and large institutions have $176M invested in ChemoCentryx, Inc. in 2014 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

29% more capital invested

Capital invested by funds: $136M → $176M (+$39.9M)

14% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 21

8% more funds holding

Funds holding: 6065 (+5)

8% more call options, than puts

Call options by funds: $185K | Put options by funds: $172K

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
65
Holders Change
+5
Holders Change %
+8.33%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
10
Increased
24
Reduced
21
Closed
5
Calls
$185K
Puts
$172K
Net Calls
+$13K
Net Calls Change
+$191K
Name Holding Trade Value Shares
Change
Change in
Stake
BI
1
BVF Inc
California
$51.7M
Capital World Investors
2
Capital World Investors
California
$22.7M +$2.05M +295,000 +9%
WA
3
Wasatch Advisors
Utah
$17.3M -$303K -43,550 -2%
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$15.2M +$7.86M +1,131,808 +98%
Franklin Resources
5
Franklin Resources
California
$12.7M +$7.24M +1,041,300 +120%
Westfield Capital Management
6
Westfield Capital Management
Massachusetts
$9.3M +$9.74M +1,402,303 New
BFA
7
BlackRock Fund Advisors
California
$8.05M +$368K +52,910 +5%
BC
8
Broadfin Capital
New York
$6.96M +$113K +16,332 +2%
Vanguard Group
9
Vanguard Group
Pennsylvania
$4.88M +$743K +106,948 +17%
State Street
10
State Street
Massachusetts
$2.35M +$157K +22,606 +7%
Northern Trust
11
Northern Trust
Illinois
$1.98M -$220K -31,723 -10%
BIT
12
BlackRock Institutional Trust
California
$1.89M +$111K +15,990 +6%
AG
13
Artal Group
Luxembourg
$1.82M
GPP
14
Great Point Partners
Connecticut
$1.66M -$5.21M -750,300 -75%
PI
15
Putnam Investments
Massachusetts
$1.33M +$6.95K +1,000 +0.5%
Renaissance Technologies
16
Renaissance Technologies
New York
$1.32M -$1.31M -188,100 -48%
BGA
17
Belmont Global Advisors
Texas
$1.16M -$4.88K -703 -0.4%
VAM
18
Visium Asset Management
New York
$1M +$1.05M +151,200 New
Deutsche Bank
19
Deutsche Bank
Germany
$975K +$153K +22,070 +18%
JP Morgan Chase
20
JP Morgan Chase
New York
$868K +$142K +20,475 +19%
BCM
21
Bridgeway Capital Management
Texas
$796K +$834K +120,000 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$794K +$224K +32,203 +37%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$739K +$71K +10,220 +10%
TCIM
24
TIAA CREF Investment Management
New York
$648K -$229K -32,979 -25%
TAM
25
Tocqueville Asset Management
New York
$534K +$559K +80,500 New

CCXI Hedge Fund Activity: Q1 2014 in Review

65 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q1 2014, worth a combined $176M — up 29% from $136M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CCXI positions and 5 closed out — a net gain of 5 holders — while 24 added to existing stakes and 21 trimmed.

The largest buyer was Westfield Capital Management, opening a new position worth an estimated $9.74M. The largest seller was Great Point Partners, cutting an estimated $5.21M.

  • 65 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q1 2014, up from 60 in Q4 2013.
  • Funds reported $176M of ChemoCentryx, Inc. stock for Q1 2014, up 29% quarter-over-quarter.
  • 10 funds opened new ChemoCentryx, Inc. positions in Q1 2014 and 5 closed out, a net change of +5 holders.
  • The largest ChemoCentryx, Inc. buyer in Q1 2014 was Westfield Capital Management, an estimated $9.74M added.
  • The largest ChemoCentryx, Inc. seller in Q1 2014 was Great Point Partners, an estimated $5.21M sold.

Based on aggregated 13F filings for Q1 2014.